SCHEMBL29930403

SCHEMBL29930403

COc1ncc(-c2cnc3c(cnn3COCC[Si](C)(C)C)c2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 3/20 0.39
DGAT1 O75907 8/20 0.34
PIK3CA P42336 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
CD274 Q9NZQ7 1/20 0.31
MAPT P10636 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
P2RX3 P56373 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
GLA P06280 1/20 0.30
CYP3A4 P08684 1/20 0.30
KMT2A Q03164 1/20 0.30
HIF1A Q16665 1/20 0.30
HSD17B10 Q99714 1/20 0.30
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30
ALOX5AP P20292 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930600 0.87 HDAC8 (0.36) DGAT1MAPTBRD4CREBBPALOX5AP
SCHEMBL29930814 0.81 PDGFRB (0.41) DGAT1
SCHEMBL29930433 0.80 DGAT1 (0.41) DGAT1PIK3CAMAPTALDH1A1HSD17B10
SCHEMBL29930423 0.80 MAP4K4 (0.40) DGAT1BRD4CREBBPALOX5APFEN1
SCHEMBL29705469 0.79 DGAT1 (0.33) DGAT1MAPT
SCHEMBL19023260 0.79 DGAT1 (0.33) DGAT1MAPT
SCHEMBL1565921 0.79 DGAT1 (0.40) DGAT1HSD17B10
SCHEMBL18188139 0.79 DGAT1 (0.33) DGAT1ALOX5APFEN1
SCHEMBL31469272 0.78 DGAT1 (0.35) DGAT1MAPTBRD4CREBBPALOX5AP
SCHEMBL29930774 0.78 DGAT1 (0.41) DGAT1GRIN1GRIN2BBRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed